---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-007294"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T12:32:43.287470+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience receives Nasdaq delisting notice for $2.5M equity non-compliance

## Summary
- Nasdaq notified Zivo on May 23, 2023 that it fails to meet $2.5M stockholders' equity requirement (Listing Rule 5550(b)).
- Company plans to request a hearing before Nasdaq Hearings Panel to stay delisting pending compliance plan.
- Previously granted extension to evidence compliance expired May 22, 2023; company was unable to cure.
- No assurance that Panel will grant continued listing or that company can regain compliance within any extension.

## SEC filing metadata
- accession: 0001654954-23-007294
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495423007294/0001654954-23-007294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423007294/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-007294
- JSON: https://secwatch.observer/filing/0001654954-23-007294.json
- Plain text: https://secwatch.observer/filing/0001654954-23-007294.txt

## Key facts
- Listing & Compliance Notices
  Zivo Bioscience, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: May 23, 2023, Zivo Biosciences, Inc. (the “Company”) was notified by the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b) (the “Rule”), as of May 22, 2023, the Company’s common stock was subject to delisting from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing bef
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495423007294/0001654954-23-007294-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.